M and B 693 en es it fr

M and B 693 Brand names, M and B 693 Analogs

M and B 693 Brand Names Mixture

  • Foot Rot Boluses (Ethylenediamine Dihydroiodide + Sulfapyridine)
  • Neutral Sulfa 50 (Sulfamethazine + Sulfapyridine + Sulfathiazole)
  • Neutral Sulfa 7 (Sulfamethazine + Sulfapyridine + Sulfathiazole)
  • Trisulfa G Liq (Sulfamethazine + Sulfapyridine + Sulfathiazole)

M and B 693 Chemical_Formula


M and B 693 RX_link

No information avaliable

M and B 693 fda sheet

M and B 693 msds (material safety sheet)

M_and_B_693 MSDS

M and B 693 Synthesis Reference

No information avaliable

M and B 693 Molecular Weight

249.29 g/mol

M and B 693 Melting Point

192 oC

M and B 693 H2O Solubility

268 mg/L

M and B 693 State


M and B 693 LogP


M and B 693 Dosage Forms


M and B 693 Indication

For the treatment of dermatitis herpetiformis, benign mucous membrane pemphigoid and pyoderma gangrenosum

M and B 693 Pharmacology

Sulfapyridine is a sulfonamide antibiotic. The sulfonamides are synthetic bacteriostatic antibiotics with a wide spectrum against most gram-positive and many gram-negative organisms. However, many strains of an individual species may be resistant. Sulfonamides inhibit multiplication of bacteria by acting as competitive inhibitors of p-aminobenzoic acid in the folic acid metabolism cycle. Bacterial sensitivity is the same for the various sulfonamides, and resistance to one sulfonamide indicates resistance to all. Most sulfonamides are readily absorbed orally. However, parenteral administration is difficult, since the soluble sulfonamide salts are highly alkaline and irritating to the tissues. The sulfonamides are widely distributed throughout all tissues. High levels are achieved in pleural, peritoneal, synovial, and ocular fluids. Although these drugs are no longer used to treat meningitis, CSF levels are high in meningeal infections. Their antibacterial action is inhibited by pus.

M and B 693 Absorption

approximately 60-80%

M and B 693 side effects and Toxicity

ORL-RAT 15800 mg/Kg

M and B 693 Patient Information


Follow the links



M and B 693 Organisms Affected

Humans and other mammals